By Professor Michael Proinsias Farrell

Journal articles

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Ji YD; McKinley SK; Farrell M; Hemingway M; Qadan M; Saillant N; Phitayakorn R, 2022, 'Operating Room Staff Perceptions of Medical Students', Journal of Surgical Education, 79, pp. 370 - 382, http://dx.doi.org/10.1016/j.jsurg.2021.10.011

Warfield SC; Bharat C; Bossarte RM; DePhilippis D; Farrell M; Hoover M; Larney S; Marshalek P; McKetin R; Degenhardt L, 2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, 331, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492

Weatherburn D; Darke S; Zahra E; Farrell M, 2022, 'Who would try (or use more) cannabis if it were legal?', Drug and Alcohol Review, 41, pp. 386 - 395, http://dx.doi.org/10.1111/dar.13360

Bosworth RJ; Borschmann R; Altice FL; Kinner SA; Dolan K; Farrell M, 2022, 'HIV/AIDS, hepatitis and tuberculosis-related mortality among incarcerated people: a global scoping review', International Journal of Prisoner Health, 18, pp. 66 - 82, http://dx.doi.org/10.1108/IJPH-02-2021-0018

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159

Mammen K; Mills L; Deacon RM; Bruno R; Dunlop A; Holmes J; Luksza J; Shakeshaft A; Farrell M; Lintzeris N, 2022, 'Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions', Drug and Alcohol Review, 41, pp. 106 - 113, http://dx.doi.org/10.1111/dar.13346

Tran AD; Chen R; Nielsen S; Zahra E; Degenhardt L; Santo T; Farrell M; Larance B, 2022, 'Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103472

Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ, 2022, 'Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials', Drug and Alcohol Review, 42, http://dx.doi.org/10.1111/dar.13511

Dewald EL; Clark DS; Casey DT; Khan SF; Mariscal D; Di Nicola P; MacGowan BJ; Hartouni EP; Rubery MS; Choate C; Nikroo A; Smalyuk VA; Landen OL; Ratledge M; Fitzsimmons P; Farrell M; Mauldin M; Rice N, 2022, 'Compensating cylindrical Hohlraum mode 4 asymmetry via capsule thickness tailoring and effects on implosions', PHYSICS OF PLASMAS, 29, http://dx.doi.org/10.1063/5.0100095

McKenna MC; McGovern E; Farrell M; Killeen RP; McGuigan C; Connolly S, 2022, 'Neurogenic muscle hypertrophy following L5 motor radiculopathy', PRACTICAL NEUROLOGY, 22, pp. 422 - 424, http://dx.doi.org/10.1136/practneurol-2022-003461

Darke S; Banister S; Farrell M; Duflou J; Lappin J, 2021, '‘Synthetic cannabis’: A dangerous misnomer', International Journal of Drug Policy, 98, pp. 103396, http://dx.doi.org/10.1016/j.drugpo.2021.103396

Yuen WS; Bruno R; Chan GCK; McCambridge J; Slade T; Clare PJ; Aiken A; Kypri K; Hutchinson D; McBride N; Boland V; Upton E; Farrell M; Mattick RP; Peacock A; Peacock A, 2021, 'The experience of physiological and psychosocial alcohol-related harms across adolescence and its association with alcohol use disorder in early adulthood: A prospective cohort study', Alcoholism Clinical and Experimental Research, 45, pp. 2518 - 2527, http://dx.doi.org/10.1111/acer.14726

Chrzanowska A; Man N; Darke S; Degenhardt L; Farrell M; Moran L; Peacock A, 2021, 'Unintentional and intentional drug poisoning deaths, Australia, 2012–2016: Drug pattern profile and demographic characteristics', Drug and Alcohol Dependence, 229, http://dx.doi.org/10.1016/j.drugalcdep.2021.109112

Courtney RJ; Tutka P; Farrell M, 2021, 'The Effect of Cytisine vs Varenicline on Smoking Cessation - Reply', JAMA Journal of the American Medical Association, 326, pp. 1872 - 1873, http://dx.doi.org/10.1001/jama.2021.16064

Quinn B; Ward B; Agius PA; Jenkinson R; Hickman M; Sutton K; Hall C; McKetin R; Farrell M; Cossar R; Dietze PM, 2021, 'A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence', Drug and Alcohol Review, 40, pp. 1239 - 1248, http://dx.doi.org/10.1111/dar.13194

Farrell M; Griffiths K; Acheson L; Bruno R, 2021, 'APSAD 2021 Conference, 7-10 November 2021, Virtual', Drug and Alcohol Review, 40, pp. S4 - S154, http://dx.doi.org/10.1111/dar.13384

McKetin R; Sutherland R; Peacock A; Farrell M; Degenhardt L, 2021, 'Patterns of smoking and injecting methamphetamine and their association with health and social outcomes', Drug and Alcohol Review, 40, pp. 1256 - 1265, http://dx.doi.org/10.1111/dar.13364

Farrell MP, 2021, 'The Faces in Einstein's Looking-Glass Self', CONTEMPORARY SOCIOLOGY-A JOURNAL OF REVIEWS, 50, pp. 470 - 472, http://dx.doi.org/10.1177/00943061211050045d

Bharat C; Degenhardt L; Dobbins T; Larney S; Farrell M; Barbieri S, 2021, 'Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109091

Hall W; Farrell M, 2021, 'What can we learn from the history of research on psychedelic drugs in the addictions?', Addiction, 116, pp. 2936 - 2938, http://dx.doi.org/10.1111/add.15560

Lewer D; Eastwood B; White M; Brothers TD; McCusker M; Copeland C; Farrell M; Petersen I, 2021, 'Fatal opioid overdoses during and shortly after hospital admissions in England: A casecrossover study', Plos Medicine, 18, http://dx.doi.org/10.1371/journal.pmed.1003759

Bargeron L; Farrell M, 2021, 'The Price Effect of Stock Repurchases: Evidence from Dual Class Firms', MANAGEMENT SCIENCE, 67, http://dx.doi.org/10.1287/mnsc.2021.4066

Santo T; Clark B; Hickman M; Grebely J; Campbell G; Sordo L; Chen A; Tran LT; Bharat C; Padmanathan P; Cousins G; Dupouy J; Kelty E; Muga R; Nosyk B; Min J; Pavarin R; Farrell M; Degenhardt L, 2021, 'Association of Opioid Agonist Treatment with All-Cause Mortality and Specific Causes of Death among People with Opioid Dependence: A Systematic Review and Meta-analysis', JAMA Psychiatry, 78, pp. 979 - 993, http://dx.doi.org/10.1001/jamapsychiatry.2021.0976

Man N; Chrzanowska A; Price O; Bruno R; Dietze PM; Sisson SA; Degenhardt L; Salom C; Morris L; Farrell M; Peacock A, 2021, 'Trends in cocaine use, markets and harms in Australia, 2003–2019', Drug and Alcohol Review, 40, pp. 946 - 956, http://dx.doi.org/10.1111/dar.13252

Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715

Yuen WS; Chan G; Bruno R; Clare PJ; Aiken A; Mattick R; Farrell M; Kypri K; Slade T; Hutchinson D; McBride N; McCambridge J; Boland V; Peacock A; Peacock A, 2021, 'Trajectories of alcohol-induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood', Addiction, 116, pp. 2039 - 2048, http://dx.doi.org/10.1111/add.15415

Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M, 2021, 'Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial', JAMA Journal of the American Medical Association, 326, pp. 56 - 64, http://dx.doi.org/10.1001/jama.2021.7621

Huang H; Sequoia K; Yamaguchi M; Boehm KJ; Engelhorn K; Walker J; Elsner F; Tomlin J; Farrell M; Fontes CJ; Colgan JP, 2021, 'Improved x-ray mass attenuation coefficient (opacity) measurements for Fe, Ni and Au', JOURNAL OF PHYSICS B-ATOMIC MOLECULAR AND OPTICAL PHYSICS, 54, http://dx.doi.org/10.1088/1361-6455/abf01c

Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297

Deacon RM; Mammen K; Bruno R; Mills L; Dunlop A; Holmes J; Jefferies M; Hall M; Shakeshaft A; Farrell M; Graham R; Lintzeris N, 2021, 'Assessing the concurrent validity, inter-rater reliability and test–re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations', Addiction, 116, pp. 1245 - 1255, http://dx.doi.org/10.1111/add.15331

Degenhardt L; Hungerford P; Nielsen S; Bruno R; Larance B; Clare PJ; Dobbins T; Hall W; Cohen M; Blyth F; Lintzeris N; Farrell M; Campbell G, 2021, 'Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults with Chronic Noncancer Pain, 2012-2018', JAMA Network Open, 4, http://dx.doi.org/10.1001/jamanetworkopen.2021.3059

McKetin R; Farrell M, 2021, 'When the evidence is not enough: is it time to rethink trial design?', Addiction, 116, pp. 711 - 712, http://dx.doi.org/10.1111/add.15273

Maher L; Harrod M; Farrell M; Wilson D, 2021, 'A Systematic Review of Interventions Used to Increase Blood Donor Compliance with Deferral Criteria', Transfusion Medicine and Hemotherapy, http://dx.doi.org/10.1159/000509027

Hohenberger M; Meezan NB; Riedel WM; Kabadi N; Forrest CJ; Aghaian L; Cappelli MA; Farrell M; Glenzer SH; Heeter B; Heredia R; Landen OL; Mackinnon AJ; Petrasso R; Shuldberg CM; Treffert F; Hsing WW, 2021, 'Developing "inverted-corona" fusion targets as high-fluence neutron sources', REVIEW OF SCIENTIFIC INSTRUMENTS, 92, http://dx.doi.org/10.1063/5.0040877

Darke S; Duflou J; Farrell M; Peacock A; Lappin J; Peacock A, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154

Jones NR; Nielsen S; Farrell M; Ali R; Gill A; Larney S; Degenhardt L, 2021, 'Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001–2018: Implications for treatment systems and potential impact on client outcomes', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108464

Campbell EM; Sangster TC; Goncharov VN; Zuegel JD; Morse SFB; Sorce C; Collins GW; Wei MS; Betti R; Regan SP; Froula DH; Dorrer C; Harding DR; Gopalaswamy V; Knauer JP; Shah R; Mannion OM; Marozas JA; Radha PB; Rosenberg MJ; Collins TJB; Christopherson AR; Solodov AA; Cao D; Palastro JP; Follett RK; Farrell M, 2021, 'Direct-drive laser fusion: status, plans and future', PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES, 379, http://dx.doi.org/10.1098/rsta.2020.0011

Casey DT; MacGowan BJ; Sater JD; Zylstra AB; Landen OL; Milovich J; Hurricane OA; Kritcher AL; Hohenberger M; Baker K; Le Pape S; Doppner T; Weber C; Huang H; Kong C; Biener J; Young C; Haan S; Nora RC; Ross S; Robey H; Stadermann M; Nikroo A; Callahan DA; Bionta RM; Hahn KD; Moore AS; Schlossberg D; Bruhn M; Sequoia K; Rice N; Farrell M; Wild C, 2021, 'Evidence of Three-Dimensional Asymmetries Seeded by High-Density Carbon-Ablator Nonuniformity in Experiments at the National Ignition Facility', PHYSICAL REVIEW LETTERS, 126, http://dx.doi.org/10.1103/PhysRevLett.126.025002

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Olson RE; Schmitt MJ; Haines BM; Kemp GE; Yeamans CB; Blue BE; Schmidt DW; Haid A; Farrell M; Bradley PA; Robey HF; Leeper RJ, 2021, 'A polar direct drive liquid deuterium-tritium wetted foam target concept for inertial confinement fusion', PHYSICS OF PLASMAS, 28, http://dx.doi.org/10.1063/5.0062590

Wang Y; Liu M; Lu Q; Farrell M; Lappin JM; Shi J; Lu L; Bao Y, 2020, 'Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis', Neurology, 95, pp. E2610 - E2621, http://dx.doi.org/10.1212/WNL.0000000000010752

Darke S; Peacock A; Duflou J; Farrell M; Lappin J; Peacock A, 2020, 'Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB)', Clinical Toxicology, 58, pp. 1028 - 1033, http://dx.doi.org/10.1080/15563650.2020.1726378

Campbell G; Noghrehchi F; Nielsen S; Clare P; Bruno R; Lintzeris N; Cohen M; Blyth F; Hall W; Larance B; Hungerford P; Dobbins T; Farrell M; Degenhardt L, 2020, 'Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study', Eclinicalmedicine, 28, http://dx.doi.org/10.1016/j.eclinm.2020.100592

McKetin R; Boden JM; Foulds JA; Najman JM; Ali R; Degenhardt L; Baker AL; Ross J; Farrell M; Weatherburn D, 2020, 'The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data', Drug and Alcohol Dependence, 216, pp. 108262, http://dx.doi.org/10.1016/j.drugalcdep.2020.108262

Cepeda JA; Vickerman P; Bruneau J; Zang G; Borquez A; Farrell M; Degenhardt L; Martin NK, 2020, 'Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis', Drug and Alcohol Dependence, 213, http://dx.doi.org/10.1016/j.drugalcdep.2020.108135

Campbell G; Darke S; Degenhardt L; Townsend H; Carter G; Draper B; Farrell M; Duflou J; Lappin J, 2020, 'Prevalence and Characteristics Associated with Chronic Noncancer Pain in Suicide Decedents: A National Study', Suicide and Life Threatening Behavior, 50, pp. 778 - 791, http://dx.doi.org/10.1111/sltb.12627

Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M; Treloar C, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389

Back to profile page